Nitazoxanide
Nitazoxanide has been studied in 5 papers since 2021: none in people yet, 4 in animals; 2 in the past year. The research so far is in animals. The newest paper, Mar 27, 2026: “Modulation of mTOR, NLRP3, and Nrf2/HO-1 signaling by atorvastatin and nitazoxanide in experimental ulcerative colitis”.
See all 5 papers on nitazoxanide
At a glance
The findings reach mice, none yet in people; independent labs found the same change in worms or flies. 4 independent labs in 3 countries; 7 trials, none about aging, 1 with no results posted.
None of its findings points the other way.
- 4 independent labs in 3 countries
- 7 trials, none about aging, 1 with no results posted
- Funders: National Natural Science Foundation of China and 8 more
- Animals3
- Model organisms1
- In silico1
What did studies of nitazoxanide find?
12Studies of nitazoxanide measured 12 outcomes, among them lifespan, NFE2L2 and NLRP3.
Lifespan
upin worms2
2 studies
Lifespan
upin worms2
Nitazoxanide extends lifespan in worms (NTZ treatment).
“In C. elegans, NTZ treatment significantly extended both lifespan and healthspan”
Model organismsNTZ treatment
International Journal of Drug Discovery and Pharmacology
Nitazoxanide improves lifespan in worms (high glucose-induced lifespan shortening).
“both nitazoxanide and tizoxanide improve high glucose-induced shortening of C. elegans lifespan”
Model organismshigh glucose-induced lifespan shortening
Acta pharmaceutica Sinica. B
Nitazoxanide extends lifespan in worms (through Akt/AMPK/sir-2.1/daf-16 pathway).
“both nitazoxanide and tizoxanide extend the lifespan and healthspan of Caenorhabditis elegans”
Model organismsthrough Akt/AMPK/sir-2.1/daf-16 pathway
Acta pharmaceutica Sinica. B
NFE2L2
upin rats1
1 study
NFE2L2
upin rats1
Nitazoxanide increases NFE2L2 in rats (acetic acid-induced colitis).
“Conversely, both agents upregulated HO-1, Nrf2, SIRT1, Wnt, and AMPK levels.”
Animalsacetic acid-induced colitiscolonn = 8
Naunyn-Schmiedeberg's archives of pharmacology
NLRP3
downin rats1
1 study
NLRP3
downin rats1
Nitazoxanide decreases NLRP3 in rats (acetic acid-induced colitis).
“decreased expression of colonic mTOR, NLRP3, DKK1, IL-6, TNF-α, and STAT3”
Animalsacetic acid-induced colitiscolonn = 8
Naunyn-Schmiedeberg's archives of pharmacology
Colitis
downin rats1
1 study
Colitis
downin rats1
Nitazoxanide decreases colitis in rats (acetic acid-induced colitis).
“Both atorvastatin and nitazoxanide significantly attenuated colitis, as evidenced by reduced disease activity scores”
Animalsacetic acid-induced colitiscolonn = 8
Naunyn-Schmiedeberg's archives of pharmacology
Neurodegeneration
downin mice1
1 study
Neurodegeneration
downin mice1
Nitazoxanide protects against neurodegeneration in D-galactose-induced accelerated aging mice.
“protected hippocampal neurons from degeneration”
Animalsin D-galactose-induced accelerated aging micehippocampus
International Journal of Drug Discovery and Pharmacology
Cognitive function
upin mice1
1 study
Cognitive function
upin mice1
Nitazoxanide improves cognitive function in D-galactose-induced accelerated aging mice.
“In the D-Gal mouse model, NTZ treatment ameliorated cognitive and physical decline”
Animalsin D-galactose-induced accelerated aging mice
International Journal of Drug Discovery and Pharmacology
Locomotor activity
upin worms1
1 study
Locomotor activity
upin worms1
Nitazoxanide improves locomotor activity in worms (NTZ treatment).
“improved locomotor activity”
Model organismsNTZ treatment
International Journal of Drug Discovery and Pharmacology
Healthspan
upin worms1
1 study
Healthspan
upin worms1
Nitazoxanide improves healthspan in worms.
“both nitazoxanide and tizoxanide extend the lifespan and healthspan of Caenorhabditis elegans”
Model organisms
Acta pharmaceutica Sinica. B
STAT3 phosphorylation
downin cells1
1 study
STAT3 phosphorylation
downin cells1
Nitazoxanide decreases STAT3 phosphorylation in cells (receptor activator of NF-κB ligand-induced osteoclastogenesis).
“osteoclastogenesis blockade elicited by NTZ resulted from inhibition of STAT3 phosphorylation”
Cellsreceptor activator of NF-κB ligand-induced osteoclastogenesis
Frontiers in pharmacology
Bone loss
downin mice1
1 study
Bone loss
downin mice1
Nitazoxanide decreases bone loss in mice (ovariectomized mice).
“NTZ (100 mg/kg/d) administration markedly reduced ovariectomy-induced bone loss by suppressing osteoclast activity.”
Animalsovariectomized micebone100 mg/kg/d3 months
Frontiers in pharmacology
All 12Fewer
Trial sponsors
Company2 trialsPhase 2/3738 people
Company1 trialPhase 2192 people
2 trialsPhase 2/3104 people
ANRS, Emerging Infectious Diseases
1 trialPhase 2/3600 people
1 trialPhase 1/2600 people
Funding
1 grant since 2021National Heart, Lung, and Blood Institute$256K